Lifeforce Review

Lifeforce — Provider Profile

Overview

Lifeforce is a performance health and longevity telehealth platform founded in 2021, targeting adults 35 and older who want to optimize healthspan rather than simply manage disease. It was co-founded with physician and longevity researcher backing and positions itself at the intersection of preventive medicine, hormone optimization, and metabolic health. GLP-1 prescriptions are available as one component of a broader metabolic optimization protocol that also covers testosterone, insulin sensitivity, cardiovascular biomarkers, and lifestyle factors.

The framing distinction Lifeforce makes — performance medicine versus weight-loss treatment — has real clinical implications for the patient experience. Most GLP-1 telehealth platforms are organized around a weight-loss disease model: a patient meets BMI criteria, receives a prescription, and is monitored for tolerability and weight outcomes. Lifeforce organizes around a different question: what is the full metabolic picture, and how does GLP-1 fit within an integrated protocol that also addresses hormones, cardiovascular risk, and body composition? For patients who are interested in that broader optimization context, the model is more coherent than receiving a GLP-1 prescription from a platform that doesn't engage with the rest of their metabolic health.

The performance and longevity framing does not alter the clinical criteria for GLP-1 prescribing. FDA-approved GLP-1 medications still require standard indications — BMI of 30 or above, or 27 or above with a weight-related comorbidity. Lifeforce physicians apply those criteria; the platform's messaging does not override clinical standards.

As of April 2026, compounded semaglutide lost its FDA shortage exemption in February 2025, and compounded tirzepatide faces 503B enforcement deadlines in April 2026. Patients should confirm Lifeforce's current GLP-1 sourcing — whether brand-name or compounded — before enrolling, as this affects both pricing and regulatory status.

Medications Offered

• GLP-1 receptor agonists (semaglutide, tirzepatide) for metabolic optimization and weight management — verify current formulary at mylifeforce.com
• Testosterone replacement therapy and hormone optimization
• Peptide protocols (availability subject to regulatory status; confirm at mylifeforce.com)
• Thyroid support where clinically indicated
• Supplement protocols integrated with lab findings

Confirm current medication availability and regulatory status at mylifeforce.com before enrolling, particularly for compounded medications given the April 2026 regulatory environment.

Pricing

All pricing is a April 2026 estimate. Medication costs (brand-name GLP-1 or compounded) are separate from membership fees and vary significantly. Verify current pricing at mylifeforce.com.

States Served

Lifeforce operates as a national telehealth platform serving patients across most U.S. states. All consultations are conducted via video. Availability by state depends on provider licensing — confirm your state is covered during the enrollment process. There are no in-person Lifeforce locations.

Insurance

• Does not accept insurance for membership fees
• Brand-name GLP-1 medications (Wegovy, Zepbound) may have insurance coverage depending on patient's plan — Lifeforce can support prior authorization documentation
• HSA/FSA accounts may be applicable for some costs
• No Medicare or Medicaid participation
• Itemized receipts available for patients pursuing out-of-network reimbursement

Consultation Process

Model: Performance medicine physician-led; video visits with comprehensive lab review

1. Complete detailed health history and intake questionnaire
2. Comprehensive lab panel ordered — drawn at a local Quest or LabCorp location
3. Initial 60-minute video consultation with a performance medicine physician to review lab results
4. Personalized protocol developed covering relevant treatment areas (metabolic, hormonal, GLP-1 if indicated)
5. Prescriptions issued and coordinated with pharmacy
6. Quarterly follow-up visits to review labs and adjust protocol; messaging access between visits

Pros

• Integrated protocol — GLP-1 prescribing is contextualized within a full metabolic and hormonal picture rather than isolated
• Comprehensive baseline lab panel included; useful for patients who want to understand their full metabolic status
• Physicians engage with performance, body composition, and longevity goals, not just weight as a disease metric
• Appropriate for patients already managing hormones who want GLP-1 added to an existing optimization protocol
• Platform built for long-term engagement, not episodic prescribing

Cons

• More expensive than standard GLP-1 telehealth platforms for patients who only need GLP-1 access
• Performance and longevity framing can be aspirational in ways that outpace the clinical evidence base for some interventions
• Regulatory uncertainty around compounded medications (as of April 2026) may affect protocol options; confirm current availability
• No in-person option; entirely telehealth
• Does not accept insurance for membership, limiting access for cost-sensitive patients

Best For

Lifeforce is best suited for adults 35 and older who are already engaged in their health metrics and want GLP-1 therapy integrated into a broader protocol that also addresses hormones, cardiovascular health, and body composition. It is a strong fit for patients who are already on testosterone or thyroid therapy and want a single platform managing the full protocol, or for patients who want their physician to engage with longevity and performance goals alongside weight management. It is not the right starting point for patients who simply need an affordable GLP-1 prescription.

Editorial Verdict

Lifeforce delivers a more integrated metabolic health platform than most GLP-1 telehealth providers, and the comprehensive lab workup provides genuine clinical value. For patients managing multiple optimization goals — hormones, metabolic health, body composition — the model is more efficient than assembling those services from separate providers.

The performance and longevity framing is well-executed but worth reading critically. Some of the platform's broader wellness positioning moves faster than the evidence base. The clinical core — physician-led care, comprehensive labs, integrated protocols — is sound. The aspirational messaging around longevity optimization should be evaluated separately from the medical services themselves.

As of April 2026, patients considering Lifeforce for GLP-1 access specifically should clarify whether the platform is prescribing brand-name medications or relying on compounded formulations. The regulatory environment for compounded semaglutide and tirzepatide has tightened significantly, and protocol availability may have changed since late 2025. Get current answers from the platform before enrolling.

Related Content

• How to Get a GLP-1 Prescription Online
• Semaglutide Cost Guide
• Who Qualifies for GLP-1 Medications
• Tirzepatide Cost Guide